ImportantSale or disposal
Strides Pharma is divesting a majority stake in its subsidiary, Pivot Path, to a consortium led by Ascent Capital for ~Rs. 100 Cr.
Strides Pharma Science LimitedSTAR · Filed with the exchange
Ascent Capital will also infuse ~Rs. 50 Cr into Pivot Path for growth.
This reclassifies Pivot Path as an associate.
No comments yet. Be the first.